DAFTAR PUSTAKA 1. AHA. Heart and Stroke Statistical Update. Dallas, Texas: American Heart Association; 2000. 2.

Murray J, Lopez A. Alternative projection of mortality and disability by cause 1990-2020 Global Burden of Disease study. Lancet 1997;349:1498-1504. 3. Martinet W, Knaapen MWM, De Meyer GRY, Herman AG, Kockx MM. Oxidative DNA Damage and Repair in Experimental Atherosclerosis Are Reversed by Dietary Lipid Lowering. Circ. Res. 2001;88(7):733-1012. 4. Miller FJ, Gutterman DD, Rios CD, Heistad DD, Davidson BL. Superoxide Production in Vascular Smooth Muscle Contributes to Oxidative Stress and Impaired Relaxation in Atherosclerosis. Circ. Res. 1998;82(12):1298-1012. 5. Ceriello A. New Insights on Oxidative Stress and Diabetic Complications May Lead to a Causal: Antioxidant Therapy. Diabetes Care 2003;26:1589-1596. 6. Lipinski B. Pathophysiology of Oxidative Stress in Diabetes Mellitus. J Diabetes Complication 2001;15:203-210. 7. Squadrito G, Pryor W. Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite and carbon dioxide. Free Radic Biol Med. 1998;25:392-403. 8. Kunsch C, Medford R. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 1999;85:753-766. 9. Kuroki T, Isshiki K, King G. Oxidative stress: the lead or supporting actor in the pathogenesis of diabetic complications. J Am Soc Nephrol 2003;14:S216-S220. 10. Qian H, Neplioueva V, Shetty GA, Channon KM, George SE. Nitric Oxide Synthase Gene Therapy Rapidly Reduces Adhesion Molecule Expression and Inflammatory Cell Infiltration in Carotid Arteries of Cholesterol-Fed Rabbits. Circulation 1999;99(23):2979-1012. 11. West NEJ, Qian H, Guzik TJ, Black E, Cai S, George SE, et al. Nitric Oxide Synthase (nNOS) Gene Transfer Modifies Venous Bypass Graft Remodeling: Effects on Vascular Smooth Muscle Cell Differentiation and Superoxide Production. Circulation 2001;104(13):1526-508. 12. Cayatte A, Palacino J, Horten K, Cohen P. Chronic Inhibition of Nitric Oxide Production Accelerates Neointima Formation and Impairs Endothelial Function in Hypercholesterolemic Rabbits. Arteioscler Thromb 1994;14:753-759. 13. Lawrence GS. Endothelial Dysfunction in Diabetes Mellitus. J Med Nus 1999;20:49-53. 14. Lawrence GS, Wahid S, Yusuf I, Kabo P, Wijaya A. High Sensitivity C-Reactive Protein in Cluster of Metabolic Syndrome. In: 8th Asia Pacific Society of Pathologists Congress; 2003; Bali, Indonesia; 2003. 15. Corseaux D, Le Tourneau T, Six I, Ezekowitz MD, Mc Fadden EP, Meurice T, et al. Enhanced Monocyte Tissue Factor Response After Experimental Balloon Angioplasty in Hypercholesterolemic Rabbit: Inhibition With Dietary L-Arginine. Circulation 1998;98(17):1776-1012. 16. Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T, Cooke JP. Novel Mechanism for Endothelial Dysfunction: Dysregulation of Dimethylarginine Dimethylaminohydrolase. Circulation 1999;99(24):3092508. 17. Wilcoz JN, Subramanian RR, Sundell CL, Tracey WR, Pollock JS, Harrison DG, et al. Expression of Multiple Isoforms of Nitric Oxide Synthase in Normal and Atherosclerotic Vessels. Arterioscler Thromb Vasc Biol 1997;17:2479-2488.

18. Tagawa T, Imaizumi T, Endo T, et al. Tole of nitric oxide in reactive hyperemia inhuman forearm vessels. Circulation 1994;90:2285-2290. 19. Brunori M, Giuffre A, Sarti P, Stubauer G, Wilson M. Nitric oxide and cellular respiration. Cell Mol Life Sci 1999;56:549-557. 20. Hayashi T, Esaki T, Muto E, Kano H, Asai Y, Thakur NK, et al. Dehydroepiandrosterone Retards Atherosclerosis Formation Through Its Conversion to Estrogen: The Possible Role of Nitric Oxide. Arteriosclerosis 2000;20(3):782-101. 21. Jeremy RW, McCarron H, Sullivan D. Effects of Dietary L-Arginine on Atherosclerosis and Endothelium-Dependent Vasodilatationin the Hypercholesterolemic Rabbit: Response According to Treatment Duration, Anatomic Site, and Sex. Circulation 1996;94(3):498-101. 22. Poderoso J, Peralta J, Lisdero C, Carreras M, Radisic M, Schopfer F, et al. Nitric oxide regulates oxygen uptake and hydrogen peroxide release by isolated beating rat heart. Am J Physiol 1998;274:C112-C119. 23. Huang A, Sun D, Kaley G, Koller A. Superoxide released to high intra-arteriolar pressure reduces nitric oxide-mediated shear stress- and agonist-induced dilations. Circ Res. 1998;83:960-965. 24. Balazy M, Kaminski P, Mao K, Tan J, Wolin M. S-Nitroglutathione: a product of the reaction between peroxynitrite and glutathione that generates nitric oxide. J Biol Chem 1998;273:32009-32015. 25. Lawrence GS, Bakri S. High Sensitivity C-Reactive Protein in Hypertensive and Dyslipidemic Patients. In: The 9th Congress of The Indonesian Heart Association, Cardiology Update-XI & Interventional Cardiology-V; 2002; Surabaya, Indonesia; 2002. 26. Grover A, Samson S, Fomin V, Werstiuk E. Effects of peroxide and superoxide on coronary artery: angiotensin II and sarcoplasmic reticulum Ca2+ pump. Am J Physiol 1995;269:C546-C553. 27. Brasier AR, III R, Eledrisi HS. Vascular Inflammation and the Renin-Angiotensin System. Arteriorscler Thromb Vascu Biol 2002;22:1257-1266. 28. Wilfert K, Drischel K, Unbehaun A, Guski H, Persson PB, Stauss HM. Vascular Response to Angiotensin II in Atherosclerosis: Role of the Baroreflex. Hypertension 2000;35(2):685-1012. 29. Yang BC, Phillips MI, Mohuczy D, Meng H, Shen L, Mehta P, et al. Increased Angiotensin II Type 1 Receptor Expression in Hypercholesterolemic Atherosclerosis in Rabbits. Arteriosclerosis 1998;18(9):1433-101. 30. Sharma AM, Janke J, Gorzelniak K, Engeli S, Luft FC. Angiotensin Blockade Prevents Type 2 Diabetes by Formation of Fat Cells. Hypertension 2002;40:609-611. 31. Blucher M, Kratzsch J, Paschke R. Plasma Levels of Tumor Necrosis Factor-alpha, Angiotensin II, Growth Hormone, and IGF-I Are Not Elevated in Insulin-Resistant Obese Individuals With Impaired Glucose Tolerance. Diabetes Cre 2001;328:328-334. 32. de las Heras N, Aragoncillo P, Maeso R, Vazquez-Perez S, Navarro-Cid J, DeGasparo M, et al. AT1 Receptor Antagonism Reduces Endothelial Dysfunction and Intimal Thickening in Atherosclerotic Rabbits. Hypertension 1999;34(4):969-101. 33. Hernandez-Presa M, Bustos C, Ortego M, Tunon J, Renedo G, Ruiz-Ortega M, et al. AngiotensinConverting Enzyme Inhibition Prevents Arterial Nuclear Factor-{kappa}B Activation, Monocyte Chemoattractant Protein-1 Expression, and Macrophage Infiltration in a Rabbit Model of Early Accelerated Atherosclerosis. Circulation 1997;95(6):1532-101. 34. Feener E, Hansen H, Folli F. Angiotensin II Inhibits Insulin Signaling in Rat Aortic Smooth Muscle Cells.

Diabetes 1997;46:212. 35. Potter DD, Sobey CG, Tompkins PK, Rossen JD, Heistad DD. Evidence That Macrophages in Atherosclerotic Lesions Contain Angiotensin II. Circulation 1998;98(8):800-1012. 36. Ushio-Fukai M, Alexander R, Akers M, Yin Q, Fujio Y, Walsh K, et al. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin in vascular smooth muscle cells. J Biol Chem 1999;274:22699-22704. 37. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman B, Griendling K, et al. Angiotensin mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contributions to altered vasomotor tone. J Clin Invest 1996;97:1916-1923. 38. Bluher M, Kratzsch J, Paschke R. Plasma Levels of Tumor Necrosis Factor-alfa, Angiotensin II, Growth Hormone, and IGF-I are not Elevated in Insulin-Resistant Obese Individuals with Impaired Glucose Tolerance. Diabetes Care 2001;24:328-334. 39. Proudler A, Crook D, Godsland I, Collins P, Rosano G, Stevenson J. Serum Angiotensin-I-Converting Enzyme Activity in Women with Cardiological Syndrome X: Relation to Blood Pressure and Lipid and Carbohydrate Metabolic Risk Markers for Coronary Heart Disease. J Clin Endocrinol Metab 1995;80:696699. 40. Griendiling K, Minieri C, Ollerenshaw J, RW. A. Angiotensin stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. 1994 1994;74:1141-1148. 41. Wang B-Y, Ho H-KV, Lin PS, Schwarzacher SP, Pollman MJ, Gibbons GH, et al. Regression of Atherosclerosis: Role of Nitric Oxide and Apoptosis. Circulation 1999;99(9):1236-1012. 42. Lin KY, Ito A, Asagami T, Tsao PS, Adimoolam S, Kimoto M, et al. Impaired Nitric Oxide Synthase Pathway in Diabetes Mellitus: Role of Asymmetric Dimethylargine and Dimethylarginine Dimethylaminohydrolase. Circulation 2002;106:987-992. 43. Radi R, Beckman J, Freeman B. Peroxynitrite oxidationof sulfhydryls: the cytotoxic potential of endothelial-derived superoxide and nitric oxide. J Biol Chem 1991;266:4244-4250. 44. Moro M, Darley-Usmar V, Lizasoain I, Su Y, Knowles R, Radomski M, et al. The formation of nitric oxide donors from peroxynitrite. Br J Pharmacol. 1995;116:1999-2004. 45. Hoshida S, Yamashita N, Kawahara K, Kuzuya T, Hori M. Amelioration by Quinapril of Myocardial Infarction Induced by Coronary Occlusion/Reperfusion in a Rabbit Model of Atherosclerosis: Possible Mechanisms. Circulation 1999;99(3):434-101. 46. Fava D, Cassone Faldetta M, Laurenti O, et al. Gliclazide improves anti-oxidant status and nitric oxide-mediated vasodilation in type 2 diabetes. Diabe Med 2002;19:752-757. 47. Giugliano D, Marfella R, Coppola L, Verrazzo G, Acampora R, Giunta R, et al. vascular effects of acute hyperglycemia in humans are reversed by L-arginine.Avidence for reduced availability of nitric oxide during hyperglycemia. Circulation 1997;95:1783-1790. 48. Wink D, Mitchell J. Chemical biology of nitric oxide: insights into regulatory cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med 1998;25:434-456.